Kurapwa Kwekutanga Kunobvumidzwa muEU kune Chinangwa Chinokonzera Sickle Cell Disease

A BATA FreeRelease 3 | eTurboNews | eTN
Avatar of Linda Hohnholz
rakanyorwa Linda Hohnholz

Brand Institute yakazivisa kudyidzana kwayo kwakabudirira neGlobal Blood Therapeutics (GBT) mukupa yavo EMA-yakatenderwa kurapa, OXBRYTA, yakaratidza kurapwa kwehemolytic anemia nekuda kwechirwere chegomarara (SCD) muvarwere vakuru nevana vane makore gumi nemaviri zvichikwira. monotherapy kana musanganiswa nehydroxycarbamide (hydroxyurea). Izvi zvinotevera kubvumidzwa kweFDA uye Health Canada kwekurapa muna 12.              

"Chikwata chese cheBrand Institute neDrug Safety Institute chinokorokotedza Global Blood Therapeutics nemvumo yeFDA yeOXBRYTA," akadaro Sachigaro weBrand Institute uye CEO, James L. Dettore. "Kurapa kwekushandura uku kune mukana wekuita mutsauko wakakura kune avo vari muEurope vanorarama nechirwere ichi chinopedza simba."

OXBRYTA ndiwo mushonga wekutanga unobvumidzwa muEurope unorambidza zvakananga sickle hemoglobin (HbS) polymerization, iyo molecular hwaro hwekurwara uye kuparadzwa kwemasero matsvuku eropa muSCD. OXBRYTA inoshanda nekuwedzera hemoglobin yakabatana neokisijeni. Sezvo oxygenated siko hemoglobin isingaite polymeri, OXBRYTA inodzivirira siko hemoglobin polymerization uye mhedzisiro yekurwara uye kuparadzwa kwemasero matsvuku eropa.

"Tinotenda kuti zita rezita reOXBRYTA rakanakira chigadzirwa," Dettore akaenderera mberi. "Pamusoro peiyo 'okisijeni' yakabatana, ichinongedza maitiro echigadzirwa, zita rine zvakawanda zvehunhu uye hunhu hwatinoteedzera pakugadzira zita idzva remishonga."

Nezvomunyori

Avatar of Linda Hohnholz

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...